ASSET PURCHASE AGREEMENT BY AND BETWEEN BAYER HEALTHCARE PHARMACEUTICALS INC. AND ARGENX BV November 20, 2020Asset Purchase Agreement • November 23rd, 2020 • Argenx Se • Biological products, (no disgnostic substances) • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 20, 2020 (the “Effective Date”), by and between ARGENX BV, a limited liability company organized under the laws of Belgium and having its registered address at Industriepark Zwijnaarde 7, 9052 Zwijnaarde, Belgium (“Buyer”), and BAYER HEALTHCARE PHARMACEUTICALS INC., a company incorporated under the laws of Delaware and having its registered address at 100 Bayer Blvd, Whippany, NJ 07981 (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
